The incidence and clinical implications of hypersensitivity to papain in an allergic population, confirmed by blinded oral challenge.
Five hundred allergy clinic patients were prick skin tested with papain, 1 mg/mL, in addition to usual local aeroallergens. Five of 475 subjects with seasonal allergic disease had positive skin tests to both papain and local pollens. None of the 25 individuals with negative skin test to pollens had skin reactivity to papain. The five subjects with positive skin tests to papain underwent double-blind placebo-papain challenges. All papain challenges were positive. Placebo challenges were negative. Papain-induced symptoms included palatal itching, watering itchy eyes, sneezing, rhinorrhea, abdominal cramps, diarrhea, and diaphoresis. Circulating papain-specific IgE was detected in all the papain-sensitive individuals, but not in control subjects. Confirmed papain sensitivity occurred in 1.05% of allergic subjects. In the papain-sensitive patients, cross-reacting antibodies with chymopapain were found. The small number of non-allergic subjects did not show any papain or chymopapain sensitivity in vitro.
D000284:Administration, Oral; D000328:Adult; D004311:Double-Blind Method; D005503:Food Additives / Q000008:administration & dosage*; D005512:Food Hypersensitivity / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D010206:Papain / Q000008:administration & dosage* / Q000276:immunology; D012882:Skin Tests
D005503:Food Additives; D007073:Immunoglobulin E; D010206:Papain